Virtu KCG Holdings’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Virtu KCG Holdings’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,186	Closed	-$219K	–	3875
2017 Q1	$219K	Sell	2,186 -2,042	-48%	-$218K	0.01%	2325
2016 Q4	$455K	Sell	4,228 -1,059	-20%	-$124K	0.01%	1612
2016 Q3	$658K	Buy	+5,287	New	+$624K	0.02%	1104
2016 Q2	–	Sell	-3,486	Closed	-$399K	–	3580
2016 Q1	$399K	Buy	+3,486	New	+$409K	0.01%	1427
2014 Q3	–	Sell	-7,253	Closed	-$323K	–	4355
2014 Q2	$323K	Buy	+7,253	New	+$296K	0.01%	2466

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Virtu KCG Holdings's CBPO Position: Q2 2017 in Review

Virtu KCG Holdings sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 2,186 shares — an estimated $219K sold.

Virtu KCG Holdings first reported a position in CBPO in Q2 2014 and held it in 5 quarters. The position peaked at $658K in Q3 2016. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Virtu KCG Holdings reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 2,186 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $219K.
Virtu KCG Holdings first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 5 quarters.
Virtu KCG Holdings's China Biologic Products Holdings, Inc. position peaked at $658K in Q3 2016.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.